Literature DB >> 11739389

Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration.

Debi K Swertfeger1, Guojun Bu, David Y Hui.   

Abstract

This research was undertaken to identify the cell surface receptor responsible for mediating apolipoprotein E (apoE) inhibition of platelet-derived growth factor (PDGF)-directed smooth muscle cell migration. Initial studies revealed the expression of the low density lipoprotein receptor (LDLR), the LDL receptor-related protein (LRP), the very low density lipoprotein receptor (VLDL), and apoE receptor-2 in mouse aortic smooth muscle cells. Smooth muscle cells isolated from LDLR-null, VLDL-null, and apoE receptor-2-null mice were responsive to apoE inhibition of PDGF-directed smooth muscle cell migration, suggesting that these receptors were not involved. An antisense RNA expression knockdown strategy, utilizing morpholino antisense RNA against LRP, was used to reduce LRP expression in smooth muscle cells to assess the role of this receptor in apoE inhibition of cell migration. Results showed that apoE was unable to inhibit PDGF-directed migration of LRP-deficient smooth muscle cells. The role of LRP in mediating apoE inhibition of PDGF-directed smooth muscle cell migration was confirmed by experiments showing that antibodies against LRP effectively suppressed apoE inhibition of PDGF-directed smooth muscle cell migration. Taken together, these results document that apoE binding to LRP is required for its inhibition of PDGF-directed smooth muscle cell migration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739389     DOI: 10.1074/jbc.M109124200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family.

Authors:  Marco Dieckmann; Martin Frederik Dietrich; Joachim Herz
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

Review 2.  Apolipoprotein E-induced cell signaling in the vessel wall.

Authors:  David Y Hui
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

3.  LRP-1 silencing prevents malignant cell invasion despite increased pericellular proteolytic activities.

Authors:  Stéphane Dedieu; Benoît Langlois; Jérôme Devy; Brice Sid; Patrick Henriet; Hervé Sartelet; Georges Bellon; Hervé Emonard; Laurent Martiny
Journal:  Mol Cell Biol       Date:  2008-03-03       Impact factor: 4.272

Review 4.  LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies.

Authors:  Anna P Lillis; Lauren B Van Duyn; Joanne E Murphy-Ullrich; Dudley K Strickland
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

5.  Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway.

Authors:  Caroline S Casey; Yuka Atagi; Yu Yamazaki; Mitsuru Shinohara; Masaya Tachibana; Yuan Fu; Guojun Bu; Takahisa Kanekiyo
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

6.  The P2Y2 receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells.

Authors:  Tixieanna Dissmore; Cheikh I Seye; Denis M Medeiros; Gary A Weisman; Barry Bradford; Laman Mamedova
Journal:  Atherosclerosis       Date:  2016-07-29       Impact factor: 5.162

7.  Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase.

Authors:  Zachary W Q Moore; David Y Hui
Journal:  J Lipid Res       Date:  2005-08-01       Impact factor: 5.922

8.  Structural and functional consequences of tyrosine phosphorylation in the LRP1 cytoplasmic domain.

Authors:  Gina N Betts; Peter van der Geer; Elizabeth A Komives
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

Review 9.  Metabolic Dysfunction in Pulmonary Arterial Hypertension.

Authors:  Tufik R Assad; Anna R Hemnes
Journal:  Curr Hypertens Rep       Date:  2015-03       Impact factor: 5.369

10.  LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation.

Authors:  Li Zhou; Yoshiharu Takayama; Philippe Boucher; Michelle D Tallquist; Joachim Herz
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.